Tag: Nasdaq:RUBY
Rubius Therapeutics Prices Upsized Public Offering of Common Stock
CAMBRIDGE Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (NASDAQ: RUBY) (“Rubius”), a clinical-stage biopharmaceutical company that is genetically...